| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 16,111,461 | 16,182,752 | 11,111,645 | | Cost of Revenue | 1,945,386 |
-
| 3,644,028 | | | Gross Profit | 14,166,075 | 16,182,752 | 7,467,617 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,083,014 | 3,499,610 | 3,082,901 | | Non Recurring | 150,838 | 145,817 | 137,311 | | Others | 2,695,346 | 503,732 | 184,842 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 8,236,877 | 12,033,593 | 4,062,563 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 183,261 | 382,954 | 583,573 | | Earnings Before Interest And Taxes | 8,472,297 | 12,416,547 | 4,496,942 | | Interest Expense | 7,021,716 | 8,722,514 | 1,543,431 | | Income Before Tax | 1,450,581 | 3,694,033 | 2,953,511 | | Income Tax Expense | 202,997 | 651,022 | 484,550 | | Minority Interest |
-
|
-
| (149,194) | | | | Net Income From Continuing Ops | 1,247,585 | 3,043,011 | 2,468,961 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 153,155 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,247,585 | 3,043,011 | 2,622,116 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,247,585 | $3,043,011 | $2,622,116 |
|
0.03% Nasdaq 
0.15 (4.08%) 
Income Statement
